China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	54.58B
Revenue (ttm)	27.18B
Net Income (ttm)	3.27B
Shares Out	1.67B
EPS (ttm)	1.96
PE Ratio	16.65
Forward PE	14.34
Dividend	1.02 (3.05%)
Ex-Dividend Date	Jun 6, 2025

Volume	11,238,600
Average Volume	9,729,253
Open	42.89
Previous Close	43.24
Day's Range	32.48 - 42.89
52-Week Range	32.48 - 52.55
Beta	0.27
RSI	16.79
Earnings Date	Aug 22, 2025

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injecti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 20,031
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2024, SHE:000999's revenue was 27.62 billion, an increase of 11.63% compared to the previous year's 24.74 billion. Earnings were 3.37 billion, an increase of 18.05%.